Page All:
Page 1
Philips Showcases Innovation With new Cardiology Solutions and Provides Pioneering Forum for Expert Dialogue at ESC 2012
MUNICH, August 24, 2012/PRNewswire/ --
With the introduction of EchoNavigator and other new solutions, Philips paves the way
for transformation in cardiovascular disease management
Royal Philips Electronics (NYSE: PHG, AEX: PHI) will present a range of new and
ground-breaking solutions, designed to demonstrate how innovation in patient-centered care
is currently helping to transform cardiovascular disease management, during the 2012
Congress of the European Society of Cardiology (ESC) in Munich.
(Logo:
http://photos.prnewswire.com/prnh/20120824/557310 )
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the
world's biggest killer, claiming 17.3 million lives a year.[1] In the European Union, it
remains the main cause of death, killing over two million people each year and costing the
economy EUR192 billion annually.[2]
"Philips is committed to providing pioneering and innovative solutions to the major
challenges the world currently faces in the management of cardiovascular disease,"
commented Eric Silfen, Chief Medical Officer, Philips Healthcare. "This year at ESC, we
want to showcase new solutions and systems that will enable clinicians to achieve safer,
enhanced patient care and outcomes in some of the most complex disease states and
procedures; thereby making a true difference to patients' lives and reducing the
significant burden of cardiac disease."
New product introduction designed to facilitate an integrated approach to treating
patients with structural heart disease
This year, Philips will introduce EchoNavigator[3], which uses a breakthrough
technology that provides a new dimension to interventional imaging by combining two live
modalities - X-ray and echocardiography - to unite operators and images in an interactive
and intuitive way for catheter based Structural Heart Disease (SHD) procedures.
EchoNavigator is developed to address some key challenges faced by clinicians; as well
as managing to improve team communication, during complex catheter based SHD procedures.
It will enable clinicians to perform the procedure efficiently by providing intelligently
integrated X-ray and echo images in one view as well as ease of system navigation, saving
valuable time and improving patient care.
"Dynamics in the cardiology field are changing. ESC provides us with the opportunity
to highlight our continued commitment in providing meaningful innovations that can help to
address the significant impact cardiovascular disease has across the world," said Bert van
Meurs, General Manager Interventional X-Ray Philips Healthcare. "EchoNavigator combines,
in a unique way, the strength of Philips in both 3D ultrasound and interventional cath
labs. It is intended to facilitate Structural Heart Disease procedures by enhancing
procedural confidence and by supporting communications within the Heart team."
Revolutionary imaging solution that reduces the barriers of dose in coronary artery
disease interventions
Philips will showcase its new AlluraClarity family[**], the first X-ray system with
the revolutionary ClarityIQ technology. AlluraClarity IQ offers industry-leading image
quality, equivalent to the Allura Xper generation, at a fraction of the dose during
coronaryographies.
Traditionally, lower radiation dose during interventional X-ray procedures means
corresponding lower image quality, which could inhibit clinicians' ability to accurately
diagnose and treat patients. The initial clinical trials have shown an average reduction
of 50% radiation dose without sacrificing image quality in coronary angiography.[4]
Studies in other types of applications, such as DSA angiography, have shown even further
dose reduction of up to 83%.[5]
These improvements will not only significantly help improve diagnostic effectiveness,
but will also ensure that patients and hospital staff will experience fewer complications
from radiation exposure.
Cardiology informatics transforms clinical management at every stage of care
The Philips IntelliSpace Cardiovascular, to be previewed in Europe for the first time
at ESC 2012, is a new integrated portfolio of software and services designed to help
streamline clinical workflow and improve operational performance across the cardiovascular
service line.
The streamlined solution addresses clinicians' needs for consistently managing the
workflow, including clinical and administrative records for the cardiovascular service
line. The solution offers one access point into consolidated patient data, advanced
clinical applications, multimodality images and reports through the patient cardiovascular
care continuum. The product is not yet available for sale.
Philips hosts Cardiology Leadership Dialogue to lead peer to peer communication
In addition, Philips is welcoming clinicians from around the world to join its unique
Cardiology Leadership Dialogue, in the form of nine expert-led clinical roundtable
discussions. These discussions will provide a forum and opportunity for clinicians to
communicate with many of the most eminent members of the cardiac care community, seeking
to address some of the most essential questions in cardiology today. Topics of the
discussions will range from improving STEMI and non-STEMI diagnosis and treatment, to the
transcatheter treatment of valve diseases.
_____________________________________
[**] Not available for sale in the U.S.
Visit Philips' ESC 2012 Booth B450, located in Hall 2B at the ICM - International
Congress Center, Munich or visit http://www.philips.com/media
About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHI) is a diversified health and well-being
company, focused on improving people's lives through meaningful innovation in the areas of
Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips
posted 2011 sales of EUR 22.6 billion and employs approximately 122,000 employees with
sales and services in more than 100 countries. The company is a leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, portable entertainment and oral
healthcare. News from Philips is located at http://www.philips.com/newscenter.
References
1. Global atlas on cardiovascular disease prevention and control. World Health
Organization. Available on
http://www.who.int/mediacentre/factsheets/fs317/en/index.html. Accessed August 2012
2. Cardiovascular disease statistics. European Heart Network. Available on
http://www.ehnheart.org/cvd-statistics.html. Accessed August 2012
3. EchoNavigator is anticipated to be CE marked in Q4 2012.
4. A Philips clinical trial study conducted together with Radboud University Nijmegen
Medical Centre, Nijmegen, Netherlands.
5. A Philips clinical trial study conducted together with St Antonius Hospital,
Nieuwegein, Netherlands
For media inquiries, please contact:
Sabine van Deursen
Philips Healthcare Communications
Tel: +31(0)6-1504-3894
E-mail: sabine.van.deursen@philips.com
Photo:
http://photos.prnewswire.com/prnh/20120824/557310
Source: Royal Philips Electronics
Philips Showcases Innovation With new Cardiology Solutions and Provides Pioneering Forum for Expert Dialogue at ESC 2012
MUNICH, August 24, 2012/PRNewswire/ --
With the introduction of EchoNavigator and other new solutions, Philips paves the way
for transformation in cardiovascular disease management
Royal Philips Electronics (NYSE: PHG, AEX: PHI) will present a range of new and
ground-breaking solutions, designed to demonstrate how innovation in patient-centered care
is currently helping to transform cardiovascular disease management, during the 2012
Congress of the European Society of Cardiology (ESC) in Munich.
(Logo:
http://photos.prnewswire.com/prnh/20120824/557310 )
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the
world's biggest killer, claiming 17.3 million lives a year.[1] In the European Union, it
remains the main cause of death, killing over two million people each year and costing the
economy EUR192 billion annually.[2]
"Philips is committed to providing pioneering and innovative solutions to the major
challenges the world currently faces in the management of cardiovascular disease,"
commented Eric Silfen, Chief Medical Officer, Philips Healthcare. "This year at ESC, we
want to showcase new solutions and systems that will enable clinicians to achieve safer,
enhanced patient care and outcomes in some of the most complex disease states and
procedures; thereby making a true difference to patients' lives and reducing the
significant burden of cardiac disease."
New product introduction designed to facilitate an integrated approach to treating
patients with structural heart disease
This year, Philips will introduce EchoNavigator[3], which uses a breakthrough
technology that provides a new dimension to interventional imaging by combining two live
modalities - X-ray and echocardiography - to unite operators and images in an interactive
and intuitive way for catheter based Structural Heart Disease (SHD) procedures.
EchoNavigator is developed to address some key challenges faced by clinicians; as well
as managing to improve team communication, during complex catheter based SHD procedures.
It will enable clinicians to perform the procedure efficiently by providing intelligently
integrated X-ray and echo images in one view as well as ease of system navigation, saving
valuable time and improving patient care.
"Dynamics in the cardiology field are changing. ESC provides us with the opportunity
to highlight our continued commitment in providing meaningful innovations that can help to
address the significant impact cardiovascular disease has across the world," said Bert van
Meurs, General Manager Interventional X-Ray Philips Healthcare. "EchoNavigator combines,
in a unique way, the strength of Philips in both 3D ultrasound and interventional cath
labs. It is intended to facilitate Structural Heart Disease procedures by enhancing
procedural confidence and by supporting communications within the Heart team."
Revolutionary imaging solution that reduces the barriers of dose in coronary artery
disease interventions
Philips will showcase its new AlluraClarity family[**], the first X-ray system with
the revolutionary ClarityIQ technology. AlluraClarity IQ offers industry-leading image
quality, equivalent to the Allura Xper generation, at a fraction of the dose during
coronaryographies.
Traditionally, lower radiation dose during interventional X-ray procedures means
corresponding lower image quality, which could inhibit clinicians' ability to accurately
diagnose and treat patients. The initial clinical trials have shown an average reduction
of 50% radiation dose without sacrificing image quality in coronary angiography.[4]
Studies in other types of applications, such as DSA angiography, have shown even further
dose reduction of up to 83%.[5]
These improvements will not only significantly help improve diagnostic effectiveness,
but will also ensure that patients and hospital staff will experience fewer complications
from radiation exposure.
Cardiology informatics transforms clinical management at every stage of care
The Philips IntelliSpace Cardiovascular, to be previewed in Europe for the first time
at ESC 2012, is a new integrated portfolio of software and services designed to help
streamline clinical workflow and improve operational performance across the cardiovascular
service line.
The streamlined solution addresses clinicians' needs for consistently managing the
workflow, including clinical and administrative records for the cardiovascular service
line. The solution offers one access point into consolidated patient data, advanced
clinical applications, multimodality images and reports through the patient cardiovascular
care continuum. The product is not yet available for sale.
Philips hosts Cardiology Leadership Dialogue to lead peer to peer communication
In addition, Philips is welcoming clinicians from around the world to join its unique
Cardiology Leadership Dialogue, in the form of nine expert-led clinical roundtable
discussions. These discussions will provide a forum and opportunity for clinicians to
communicate with many of the most eminent members of the cardiac care community, seeking
to address some of the most essential questions in cardiology today. Topics of the
discussions will range from improving STEMI and non-STEMI diagnosis and treatment, to the
transcatheter treatment of valve diseases.
_____________________________________
[**] Not available for sale in the U.S.
Visit Philips' ESC 2012 Booth B450, located in Hall 2B at the ICM - International
Congress Center, Munich or visit http://www.philips.com/media
About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHI) is a diversified health and well-being
company, focused on improving people's lives through meaningful innovation in the areas of
Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips
posted 2011 sales of EUR 22.6 billion and employs approximately 122,000 employees with
sales and services in more than 100 countries. The company is a leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, portable entertainment and oral
healthcare. News from Philips is located at http://www.philips.com/newscenter.
References
1. Global atlas on cardiovascular disease prevention and control. World Health
Organization. Available on
http://www.who.int/mediacentre/factsheets/fs317/en/index.html. Accessed August 2012
2. Cardiovascular disease statistics. European Heart Network. Available on
http://www.ehnheart.org/cvd-statistics.html. Accessed August 2012
3. EchoNavigator is anticipated to be CE marked in Q4 2012.
4. A Philips clinical trial study conducted together with Radboud University Nijmegen
Medical Centre, Nijmegen, Netherlands.
5. A Philips clinical trial study conducted together with St Antonius Hospital,
Nieuwegein, Netherlands
For media inquiries, please contact:
Sabine van Deursen
Philips Healthcare Communications
Tel: +31(0)6-1504-3894
E-mail: sabine.van.deursen@philips.com
Photo:
http://photos.prnewswire.com/prnh/20120824/557310
Source: Royal Philips Electronics